MyoPax
Creating advanced regenerative stem cell therapies to combat the effects of muscle illnesses.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
€2.5m | Grant | ||
| Total Funding | 000k | ||
Related Content
MyoPax is focused on advancing muscle regeneration therapies for patients suffering from muscle defects and degenerative muscle conditions. Their research-driven approach utilizes cutting-edge techniques such as stem cell manufacturing and gene-editing to address various forms of muscle degeneration, including congenital conditions and muscle wasting due to illness. With a core mission centered on restoring muscle function and enhancing quality of life, MyoPax collaborates with medical professionals to pioneer new treatments that leverage the latest biotechnological advancements.
Keywords: MyoPax, muscle regeneration, stem cell therapy, gene-editing, muscle defects, degenerative diseases, muscle therapy, biotechnology.